Results
|
1.
|
Underuse of exon mutational analysis for gastrointestinal stromal tumors. MedStar authors:
- Al-Refaie, Waddah B
- Quadri, Humair S
Year: 2018
Citation: - Journal of Surgical Research. 231:43-48, 2018 Nov.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Al-Refaie WB, Bartholomew AJ, Dohnalek H, Haddad NG, Marshall JL, O'Neill SC, Prins PA, Quadri HS
|
|
2.
|
Frequency of Takotsubo Cardiomyopathy in Adult Patients Receiving Chemotherapy (from a 5-Year Nationwide Inpatient Study). MedStar authors:
Year: 2019
Citation: - American Journal of Cardiology. 123(4):667-673, 2019 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbas SA, Barac A, Desai R, Durairaj A, Fong HK, Goyal H, Hung O, Kumar G, Sachdeva R, Yusuf SW
|
|
3.
|
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer. MedStar authors:
- Carvalho, Filipe
- Egan, Jillian
- Hwang, Jonathan J
- Krasnow, Ross
- Lynch, John H
- Stamatakis, Lambros
- Zeymo, Alexander
Year: 2020
Citation: - Investigative And Clinical Urology. 61(4):390-396, 2020 07.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
All authors: - Carvalho FL, Egan J, Hwang J, Kelly CH, Kowalczyk KJ, Krasnow RE, Lynch JH, Stamatakis L, Zeymo A, Zheng C
|
|
4.
|
|
|
5.
|
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. [] MedStar authors:
Year: 2014
Citation: - European heart journal cardiovascular Imaging. 15(10):1063-93, 2014 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Agler DA, Badano LP, Banchs J, Barac A, Cardinale D, Carver J, Cerqueira M, DeCara JM, Edvardsen T, Ewer MS, Flamm SD, Force T, Galderisi M, Ganame J, Griffin BP, Jerusalem G, Ky B, Lancellotti P, Liu JE, Magalhaes A, Marwick T, Plana JC, Sanchez LY, Scherrer-Crosbie M, Sebag IA, Sicari R, Villarraga HR
|
|
6.
|
Importance of gender in diffuse malignant peritoneal mesothelioma. MedStar authors:
Year: 2012
Citation: - Annals of Oncology. 23(6):1494-8, 2012 Jun.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Cao C, Chua TC, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Peritoneal Surface Malignancy Group, Piso P, Sugarbaker PH, Yan TD
|
|
7.
|
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. MedStar authors:
Year: 2021
Citation: - JAMA Surgery. 156(3):e206363, 2021 03 01.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baratti D, Barretta F, Barrios P, Ceelen W, de Hingh I, Deraco M, Glehen O, Goere D, Gomez-Portilla A, Gonzalez-Moreno S, Kusamura S, Levine EA, Moran BJ, Morris DL, Nizri E, Pelz JOW, Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE), Piso P, Quenet F, Sardi A, Sugarbaker PH, Van Der Speeten K, Villeneuve L, Yonemura Y
|
|
8.
|
Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone. MedStar authors:
Year: 2018
Citation: - World Journal of Surgical Oncology. 16(1):191, 2018 Sep 19.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bach BA, Braun A, Chawla S, Choy E, Engellau J, Feng A, Gelderblom H, Grimer R, Henshaw R, Jacobs I, O'Neal M, Reichardt P, Roberts ZJ, Seeger L
|
|
9.
|
|
|
10.
|
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
- Herbolsheimer, Pia M
- Jelinek, James S
- Kapoor, R
- Perry, David J
- Smith, Karen L
- Swain, Sandra M
- Verma, Nitin
- Veytsman, Irina
Citation: - Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
|
|
11.
|
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors:
- Blackburn, Matthew J
- Lynce, Filipa
Year: 2018
Citation: - Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
All authors: - Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H
|
|
12.
|
|
|
13.
|
|
|
14.
|
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
Year: 2020
Citation: - Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
|
|
15.
|
|
|
16.
|
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
Year: 2019
Citation: - Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
|
|
17.
|
|
|
18.
|
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors:
Year: 2012
Citation: - Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N
|
|
19.
|
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. MedStar authors:
- Barett, Christina
- Bikas, Athanasios
- Burman, Kenneth D
- Clark, Brandon G
- Desale, Sameer
- Gandhi, Rahul
- Jelinek, James S
- Kundra, Priya
- Mete, Mihriye
- O'Keefe, Kaitlyn
- Wartofsky, Leonard
- Wexler, Jason
- Wray, Lynette
Year: 2016
Citation: - European Journal of Endocrinology. 174(3):373-80, 2016 Mar.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Radiology
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Barett C, Bikas A, Burman KD, Clark BG, Desale S, Gandhi R, Jelinek JS, Kundra P, Mete M, O'Keefe K, Wartofsky L, Wexler JA, Wray L
|